16,230 Shares in Revvity, Inc. (NYSE:RVTY) Purchased by Everence Capital Management Inc.

Everence Capital Management Inc. purchased a new stake in Revvity, Inc. (NYSE:RVTY) during the fourth quarter, HoldingsChannel.com reports. The firm purchased 16,230 shares of the company’s stock, valued at approximately $1,774,000.

Several other large investors have also recently added to or reduced their stakes in the company. Vanguard Group Inc. acquired a new stake in shares of Revvity in the third quarter valued at $1,579,487,000. Ceredex Value Advisors LLC acquired a new stake in Revvity in the 4th quarter valued at about $108,353,000. Sumitomo Mitsui Trust Holdings Inc. acquired a new stake in Revvity in the 4th quarter valued at about $33,568,000. Boston Trust Walden Corp bought a new position in shares of Revvity in the fourth quarter worth about $25,154,000. Finally, KBC Group NV bought a new stake in shares of Revvity during the third quarter valued at approximately $25,301,000. 86.65% of the stock is owned by institutional investors.

Revvity Price Performance

Shares of RVTY stock opened at $100.30 on Wednesday. The firm has a market capitalization of $12.39 billion, a price-to-earnings ratio of 18.24, a price-to-earnings-growth ratio of 2.66 and a beta of 1.09. Revvity, Inc. has a 12-month low of $79.50 and a 12-month high of $137.09. The company has a quick ratio of 1.77, a current ratio of 2.07 and a debt-to-equity ratio of 0.40. The firm has a fifty day moving average of $104.96 and a 200-day moving average of $101.71.

Revvity (NYSE:RVTY) last posted its earnings results on Thursday, February 1st. The company reported $1.25 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.15 by $0.10. The firm had revenue of $695.90 million during the quarter. Revvity had a return on equity of 7.41% and a net margin of 25.20%. On average, equities research analysts forecast that Revvity, Inc. will post 4.65 earnings per share for the current year.

Revvity Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, May 10th. Shareholders of record on Friday, April 19th will be paid a $0.07 dividend. This represents a $0.28 dividend on an annualized basis and a yield of 0.28%. The ex-dividend date is Thursday, April 18th. Revvity’s payout ratio is currently 5.09%.

Analysts Set New Price Targets

Several research analysts recently weighed in on RVTY shares. KeyCorp boosted their price objective on shares of Revvity from $110.00 to $126.00 and gave the stock an “overweight” rating in a research report on Friday, February 2nd. Raymond James upped their price target on Revvity from $106.00 to $127.00 and gave the company an “outperform” rating in a research note on Friday, February 2nd. Wells Fargo & Company began coverage on Revvity in a research report on Tuesday, December 19th. They issued an “equal weight” rating and a $95.00 price objective for the company. Stifel Nicolaus upped their target price on shares of Revvity from $95.00 to $110.00 and gave the company a “hold” rating in a research report on Friday, February 2nd. Finally, Evercore ISI raised shares of Revvity from an “in-line” rating to an “outperform” rating and boosted their price target for the stock from $88.00 to $125.00 in a research note on Thursday, January 4th. Six analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $118.91.

Insider Activity

In related news, insider Prahlad R. Singh sold 21,217 shares of the company’s stock in a transaction on Monday, February 5th. The shares were sold at an average price of $104.28, for a total value of $2,212,508.76. Following the completion of the transaction, the insider now directly owns 92,801 shares of the company’s stock, valued at approximately $9,677,288.28. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Corporate insiders own 0.60% of the company’s stock.

Revvity Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.